Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Assets Average (2019 - 2025)

Historic Assets Average for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to $103.1 million.

  • Eton Pharmaceuticals' Assets Average rose 20472.04% to $103.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.1 million, marking a year-over-year increase of 20472.04%. This contributed to the annual value of $53.9 million for FY2024, which is 9000.0% up from last year.
  • Eton Pharmaceuticals' Assets Average amounted to $103.1 million in Q3 2025, which was up 20472.04% from $92.9 million recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' Assets Average registered a high of $103.1 million during Q3 2025, and its lowest value of $22.3 million during Q3 2022.
  • Moreover, its 5-year median value for Assets Average was $30.5 million (2021), whereas its average is $39.6 million.
  • As far as peak fluctuations go, Eton Pharmaceuticals' Assets Average plummeted by 2430.76% in 2022, and later skyrocketed by 20472.04% in 2025.
  • Quarter analysis of 5 years shows Eton Pharmaceuticals' Assets Average stood at $27.0 million in 2021, then dropped by 13.91% to $23.3 million in 2022, then surged by 35.91% to $31.6 million in 2023, then skyrocketed by 76.97% to $56.0 million in 2024, then soared by 84.15% to $103.1 million in 2025.
  • Its last three reported values are $103.1 million in Q3 2025, $92.9 million for Q2 2025, and $80.1 million during Q1 2025.